A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Multi-omic analysis of the immune profile of COVID-19 patients showed a significant role of the AP-1/p38MAPK pathway in disease progression. Proteomic analysis of plasma revealed increased levels of IL-6, IL-8, CCL2, CLEC11A, CCL20, CXCL10 and CCL19
Distinct characteristics of multisystem inflammatory syndrome in children in Poland
Artykuł naukowy opublikowany w Scientific Reports przedstawia wyniki działania krajowego rejestru zaburzeń zapalnych u dzieci (MultiOrgan Inflammatory Syndromes Related Study – MOIS-CoR). W ramach badania
The FDA approved Paxlovid as the first oral drug to treat COVID-19
FDA has approved the use of the oral tablet Paxlovid for the treatment of mild-to-moderate COVID-19 in adults and children over 12 years of age
COVID-19 Data Portal Poland has become part of ELIXIR-CONVERGE
As of December 2021, the development of infrastructure and service offered by the Institute of Bioorganic Chemistry PAS together with the affiliated Poznan Supercomputing and Networking Center via COVID-19 Data Portal Poland (COVID-HUB)
Omicron likely to weaken COVID vaccine protection, but boosters should improve immunity
Initial laboratory studies by Pfizer-BioNTech showed that three doses of BNT162b2 vaccine increased the titer of neutralizing antibodies against the new variant SARS-CoV-2 Omicron (B.1.1.529)
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
A study published in Cell using transcriptomic, radiological and histopathological data showed that SARS-CoV-2 infection induced an influx of profibrotic macrophages (CD163) into the lung.